Deepika Pakianathan, Director at Karyopharm Therapeutics Inc. (KPTI), bought 45,454 shares at $33.00 ($1.5M) on 2015-01-12, disclosed to the SEC on 2015-01-14.
Open-market purchase of $1.5M KPTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.00 | 440 | $15K | 1.0% |
| 2 | $33.00 | 45,014 | $1.5M | 99.0% |
| Total | $33.00 avg | 45,454 | $1.5M | 100% |
| Filing → |
| KPTI | SELL | 2024-06-04 | $1.4M | — | Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |